Skip to main content
OpenTrials

Clinical trial condition

Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer

Explore clinical trials studying Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer trial results

Not Yet Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab Soravtansine-gynx in Adults With Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer in a Real-World Setting

NCT07687602

Conditions
Folate Receptor-Alpha Positive Platinum-Resistant Fallopian Tube Cancer, Folate Receptor-Alpha Positive Platinum-Resistant High-Grade Serous Epithelial Ovarian Cancer, Folate Receptor-Alpha Positive Platinum-Resistant Primary Peritoneal Cancer
Locations

Not specified

View Trial Details

Related conditions